123 related articles for article (PubMed ID: 24759894)
21. Economic Approaches to Estimating Benefits of Regulations Affecting Addictive Goods.
Cutler DM; Jessup AI; Kenkel DS; Starr MA
Am J Prev Med; 2016 May; 50(5 Suppl 1):S20-S26. PubMed ID: 27102854
[TBL] [Abstract][Full Text] [Related]
22. [Economic evaluation of smoking cessation interventions: have we overlooked something].
Trapero-Bertran M
Arch Bronconeumol; 2009 May; 45(5):209-11. PubMed ID: 19395140
[No Abstract] [Full Text] [Related]
23. [Money or life?].
Wildner M
Gesundheitswesen; 2008 Jun; 70(6):327-8. PubMed ID: 18661454
[No Abstract] [Full Text] [Related]
24. Are lower income smokers more price sensitive?: the evidence from Korean cigarette tax increases.
Choi SE
Tob Control; 2016 Mar; 25(2):141-6. PubMed ID: 25430738
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
[TBL] [Abstract][Full Text] [Related]
26. Cost effectiveness of full coverage of the medical management of smoking cessation in France.
Chevreul K; Cadier B; Durand-Zaleski I; Chan E; Thomas D
Tob Control; 2014 May; 23(3):223-30. PubMed ID: 23197369
[TBL] [Abstract][Full Text] [Related]
27. Budgetary Impact Analysis of Reimbursement Varenicline for the Smoking-Cessation Treatment in Patients with Cardiovascular Diseases, Chronic Obstructive Pulmonary Disease or Type-2 Diabetes Mellitus: A National Health System Perspective.
Cedillo S; Sicras-Mainar A; Jiménez-Ruiz CA; Fernández de Bobadilla J; Rejas-Gutiérrez J
Eur Addict Res; 2017; 23(1):7-18. PubMed ID: 27794567
[TBL] [Abstract][Full Text] [Related]
28. Estimating the short-term clinical and economic benefits of smoking cessation: do we have it right?
Menzin J; Lines LM; Marton J
Expert Rev Pharmacoecon Outcomes Res; 2009 Jun; 9(3):257-64. PubMed ID: 19527098
[TBL] [Abstract][Full Text] [Related]
29. A cost-effectiveness analysis of a community pharmacist-based smoking cessation programme in Thailand.
Thavorn K; Chaiyakunapruk N
Tob Control; 2008 Jun; 17(3):177-82. PubMed ID: 18285385
[TBL] [Abstract][Full Text] [Related]
30. Smoking cessation treatment in a public-health context.
Warner KE; Mackay JL
Lancet; 2008 Jun; 371(9629):1976-8. PubMed ID: 18555898
[No Abstract] [Full Text] [Related]
31. Does smuggling negate the impact of a tobacco tax increase?
Tsui TC
Tob Control; 2016 May; 25(3):361-2. PubMed ID: 26085122
[No Abstract] [Full Text] [Related]
32. A simulation model to predict the fiscal and public health impact of a change in cigarette excise taxes.
van Walbeek C
Tob Control; 2010 Feb; 19(1):31-6. PubMed ID: 19850550
[TBL] [Abstract][Full Text] [Related]
33. Buproprion, public funding, and smoking cessation.
Bloomfield A
N Z Med J; 2005 Jul; 118(1218):U1576. PubMed ID: 16027759
[No Abstract] [Full Text] [Related]
34. Economic evaluations of smoking cessation and relapse prevention programs for pregnant women: a systematic review.
Ruger JP; Emmons KM
Value Health; 2008; 11(2):180-90. PubMed ID: 17854435
[TBL] [Abstract][Full Text] [Related]
35. Cost-Effectiveness of Integrating Tobacco Cessation Into Post-Traumatic Stress Disorder Treatment.
Barnett PG; Jeffers A; Smith MW; Chow BK; McFall M; Saxon AJ
Nicotine Tob Res; 2016 Mar; 18(3):267-74. PubMed ID: 25943761
[TBL] [Abstract][Full Text] [Related]
36. The economic and social costs of lung cancer and the economics of smoking prevention.
Godfrey C
Monaldi Arch Chest Dis; 2001 Oct; 56(5):458-61. PubMed ID: 11887505
[TBL] [Abstract][Full Text] [Related]
37. Encouraging smokers to quit: the cost effectiveness of reimbursing the costs of smoking cessation treatment.
Kaper J; Wagena EJ; van Schayck CP; Severens JL
Pharmacoeconomics; 2006; 24(5):453-64. PubMed ID: 16706571
[TBL] [Abstract][Full Text] [Related]
38. Tobacco use: the impact of prices.
Leverett M; Ashe M; Gerard S; Jenson J; Woollery T
J Law Med Ethics; 2002; 30(3 Suppl):88-95. PubMed ID: 12508509
[TBL] [Abstract][Full Text] [Related]
39. From the Centers for Disease Control. Public health focus: effectiveness of smoking-control strategies--United States.
JAMA; 1992 Oct; 268(13):1645-6. PubMed ID: 1527864
[No Abstract] [Full Text] [Related]
40. [Cost effectiveness of workplace smoking policies].
Raaijmakers T; van den Borne I
Rev Esp Salud Publica; 2003; 77(1):97-116. PubMed ID: 12696390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
